Global Drugs and Diagnostics for Hematological Disorders

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
36
Global Drugs and Diagnostics for Hematological Disorders Markets, 2020

Dublin, April 05, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Drugs and Diagnostics for Hematological Disorders: Global Markets" report to their offering. The global market for hematology drugs and diagnostics is expected to grow from nearly $86.5 billion in 2015 to $124.3 billion in 2020 at a compound annual growth rate of 7.5% from 2015-2020. The scope of this study covers instruments, reagents, testing, screening technology and the therapeutics markets for hematological disorders, including hemophilia and blood cancers. The report also discusses the regulatory environment, current technologies, new technologies, hematological disorders and cancer incidence, market projections and market share, along with latest trends, and clinical and new developments.

This report provides: - An overview of the global market for drugs and diagnostics for hematological disorders. - Analyses of global market trends, with data from2015, and projections of CAGRs through 2020. - A breakdown of the market by hematological diseases, hematological cancers, and hematological diagnostics. - A review of blood cancers, such as various types of leukemia, lymphoma, and myeloma, and their therapies. - Evaluation of the market's dynamics, specifically growth drivers, restraints, and opportunities - Delineation of drugs approved by the FDA for hematological disorders. - Profiles of key companies in the industry. Key Topics Covered: 1: Introduction - Study Goals And Objectives - Reasons For Doing This Study - Intended Audience - Scope Of The Study - Methodology - Information Sources 2: Summary 3: Hematalogical Disorders - Blood - Blood Disorders/Diseases 4: Hematological Cancers - Classic Classification 5: Leukemia - Lymphocytic Leukemias - Myelogenous Leukemias - Conclusions 6: Lymphoma - Overview - Non-Hodgkin Lymphoma - Lymphoma Treatment 7: Multiple Myeloma - Overview - Conclusions 8: Myelodysplastic Syndromes - Classes Of Mds - Diagnosis And Tests - Prognosis And Treatment Options - Drug Profiles - Conclusions 9: Myeloproliferative Disorders - Types Of Chronic Myeloproliferative Disorders - Stages Of Chronic Myeloproliferative Disorders - Diagnosis - Treatment - Polycythemia Vera - Chronic Idiopathic Myelofibrosis - Essential Thrombocythemia - Chronic Neutrophilic Leukemia - Chronic Eosinophilic Leukemia - Summary 10: Epidemiology Of Hematological Cancers - India - Kenya - Worldwide Incidence Of Blood Cancers - Leukemia - Lymphoma - Myeloma - Myelodysplastic Syndromes - Blood Diseases And Incidence - Bleeding Disorders 11: Hematology Instruments And Reagents: A Global Market Perspective - Hematological Malignancies - Market Dynamics: Hematology Instruments And Reagents - Hematology Test Products And Market - Conclusions 12: Global Market For Treatments For Hematological Disorders - Therapeutic Drug Market - Conclusions 13: Hematological Cancer Therapies Market - Overview - Hematological Cancers Drug Market - Classification Of Hematologic Malignancies - Global Cytotoxic Therapies Market - Leukemia Market And Challenges - Chronic Myelogenous Leukemia Market - Acute Lymphocytic Leukemia Market - Acute Myeloid Leukemia (Aml) Market - Chronic Lymphocytic Leukemia Market - Lymphoma Drug Market - Multiple Myeloma Treatment Market - Myelodysplastic Syndrome Market - Myeloproliferative Disorders - Market For Essential Thrombocytosis (Et) - Myelofibrosis Market - Polycythemia Vera (Pv) Therapeutics Market 14: Patent Landscape And Current Developments - Hematological Cancer Drug Patent Expiries - New Approvals 15: Selected Company Profiles - Abbott Laboratories - Abon Pharmaceuticals - Ambit Biosciences - Amgen - Amphastar Pharmaceuticals - Ariad Pharmaceuticals - Astellas Pharma Us - Astex Pharmaceuticals - Astrazeneca - Baxalta Inc. - Baxter Healthcare Corp. - Bayer Healthcare Pharmaceuticals - Biogen Idec - Boehringer Ingelheim Gmbh - Bristol-Myers Squibb - Celgene Corp. - Chugai Pharmaceutical - C.R. Bard - CZ Biomed Corp. - Daiichi Sankyo Co. Ltd. - Deciphera Pharmaceuticals - Diagnocure - Eisai Inc. - ELI Lilly And Co. - Enzon Pharmaceuticals - Erytech Pharma Sa - Exelixis - GE Healthcare - Genentech Inc. - Genmab Inc. - Gilead Sciences - Glaxosmithkline - Hologic - Horiba Ltd. - Johnson & Johnson - The Medicines Co. - Medkoo Biosciences - Momenta Pharmaceuticals - Noxxon Pharma Ag - Portola Pharmaceuticals Inc. - Opko Health - Otsuka Pharmaceutical - Pfizer - Pharmacyclics - Roche Diagnostics - Sandoz International Gmbh - Sanofi - Siemens AG - Spectrum Pharmaceuticals - Teva Pharmaceutical Industries Ltd. - Watson Pharmaceuticals Inc. - YM Biosciences Inc. For more information about this report visit http://www.researchandmarkets.com/research/kckpfz/drugs_and

CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Related Topics: Diagnostics, Hematological Drugs

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pyxus Starts Exchange Offer for 8.50% Notes, 2027

Updated Category News Views 70

Pyxus Restructures Via Exchange Offer Pites, it's time for Pyxus International to show its hand. The global agricultural player has rolled up its sleeves, kicking off an exchange offer for its 8.50% notes maturing in 2027. With $148.3 million hanging in the balance, this move is their shot at managing debt and keeping things steady—like a farmer making sure the...

Continue Reading
Nevada Organic Phosphate Cancels Share Consolidation Plan

Updated Category News Views 42

Unexpected Turn for Nevada Organic Phosphate In an abrupt twist that surprised some investors, Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF) (FSE: ZV8), the Canadian trailblazer in organic phosphate mining, called off its proposed share consolidation. Dropping the plan wasn't just a stroke of luck; it came after hearing the grumblings of shareholders concerned...

Continue Reading
Inner City Visions Celebrates Two Decades of Impact

Updated Category News Views 136

Alfred Lomas' Transformation Fuels Lasting Change Once upon a time, Alfred Lomas was known as a brawler in the rough patches of South L.A., running with gangs and entangled in violence. But the story flipped, and instead of leaning into chaos, Lomas leaned into hope. That personal turnaround isn't just a headline—it's the crux behind Inner City Visions (ICV), the...

Continue Reading
Elong Kicks Off Central Asia Strategy with Almaty Launch

Updated Category News Views 64

Elong's Strategic Move into Central Asia When a company like Elong Hotel Technology decides to plant its flag in Central Asia, it’s more than just another overseas venture. This brand launch in Almaty is a bold statement—a signal that they're here to shake things up in a region ripe for development but lacking in hotel chains. With only about 20% penetration for local...

Continue Reading
PMET's High-Stakes Call on Shaakichiuwaanaan Update

Updated Category News Views 25

Inside PMET Resources' Critical Investor Briefing Now, this is the kind of investor chatter that cuts to the core of PMET's game plan. We're talking the big guns coming out with PMET Resources (TSX: PMET) as they gear up for what's poised to be a tell-all investor teleconference about their Shaakichiuwaanaan Project. Yep, mark your calendars because on Tuesday, November...

Continue Reading
GFL Stays Public: Board Sees Growth Beyond Buyout

Updated Category News Views 69

GFL Environmental Says 'No Thanks' to Takeover Bids Wall Street loves a juicy M&A story, but GFL Environmental decided it’s not playing ball. In a world where companies seem to flip like properties on a hot market, GFL has boldly told prospective buyers to buzz off. They want to stay public, continue carving their path without the trappings of private equity overlords....

Continue Reading
HI-CHEW® Holiday Mix Debuts Three Seasonal Flavors

Updated Category News Views 156

HI-CHEW® Puts Holiday Cheer on the Shelves In the candy aisle, it’s never just about sugar—it’s about the flavor journey. This year, HI-CHEW® is pulling off a sweet, festive coup with its first-ever Holiday Mix, making sure that your taste buds aren't left out in the cold. But hey, I’m a seasoned investor talking about candy here, not stocks. Unwrapping the New...

Continue Reading
First Graphene Taps Deeper into US Defense Market

Updated Category News Views 136

Graphene Making Waves in Defense Fresh off the press, folks. First Graphene Limited is struttin' onto the US defense scene with a repeat order for its PureGRAPH®—a big deal in the realm of electrically conductive inks. The tally comes to around A$35,000 in an order from a longtime American customer. We're talking about inks that print circuits, sensors, and more,...

Continue Reading
Quantinuum & RIKEN Propel Japan's Quantum Leap Forward

Updated Category News Views 81

Quantum Computing: Japan's Bold New Frontier Quantum computing's buzz is getting louder, and the big players like Quantinuum and RIKEN ain't sitting on their hands. They've rolled up their sleeves to ramp up Japan's quantum-AI supercomputing game with the recent beef-up of Quantinuum's Reimei to its H2 system, putting Japan at the cutting edge of hybrid computing. The...

Continue Reading
Solar Cooking Revolution: InventHelp's Latest Innovation

Updated Category News Views 16

A Bright Idea Shines with Solar Cooking Some days, you stumble across an idea that just seems destined to shake things up, and COOK SOL SOLAR POWER COOKER might just be one of those spark plugs ready to ignite the world of outdoor cooking. Invented by a plucky thinker from Florence, South Carolina, this little gadget isn't just about frying up eggs on a camping trip. Nah,...

Continue Reading

Top 5 Most Recently Viewed Articles

GTIA Introduces Significant Charitable Giving Initiative

Updated Category News Views 253

GTIA's Charitable Commitment for 2025 During a notable event at ChannelCon, the Global Technology Industry Association (GTIA) revealed an ambitious plan to contribute $1.5 million to charitable causes in 2025. This pledge includes a noteworthy $50,000 grant awarded to a local nonprofit organization focused on supporting underprivileged youth. The announcement illustrates...

Continue Reading
Revolutionary TIL Therapy Shows Promise for Treating Tumors

Updated Category News Views 40

Advancements in Tumor-Infiltrating Lymphocyte Therapy Turnstone Biologics is at the forefront of developing a cutting-edge approach to combat solid tumors through the innovation of Selected Tumor-Infiltrating Lymphocyte (TIL) therapy. Their next-generation Selected TIL technology is engineered to selectively expand the most effective tumor-reactive T cells, positioning it...

Continue Reading
Arc and Curtin Maritime Forge Alliance for Electric Tugboats

Updated Category News Views 194

Arc Teams Up with Curtin Maritime for Hybrid Tugboats In a significant move towards the future of maritime operations, Arc has announced a substantial contract with Curtin Maritime, highlighting a $160 million deal aimed at producing eight hybrid-electric tugboats. This development represents a pivotal step in the electrification of commercial vessels, promising to...

Continue Reading
MP Materials Surges: Key Factors Behind the 531% Growth

Updated Category News Views 237

MP Materials: A Stellar Performance MP Materials Corp (NYSE: MP) has recently seen its stock skyrocket by an astonishing 531%, particularly from its notable four-year low. This surge, characterized by a robust upward trend over the past months, has captured the attention of investors and industry watchers alike. Two pivotal factors—partnerships with the Pentagon and...

Continue Reading
FP Movement Expands to Savannah: Opening Marks New Era

Updated Category News Views 16

FP Movement Steps into Savannah with New Boutique Alright, folks, there’s something brewing down in the historic streets of Savannah, Georgia. FP Movement, Free People's dynamic activewear line, is unveiling its newest outpost at 217 W Broughton St. on May 22, 2026. This isn't just another storefront—it's a strategic play to capture an uptick in lifestyle-oriented...

Continue Reading